---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-004824"
form_type: "8-K"
ticker: "PEPG"
cik: "0001835597"
company_name: "PepGen Inc."
filed_at: "2024-01-17T23:59:59+00:00"
generated_at: "2026-06-06T22:41:30.945535+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# PepGen appoints Mary Beth DeLena as General Counsel and Secretary

## Summary
- Mary Beth DeLena joins PepGen as General Counsel and Secretary, effective January 17, 2024.
- She brings over 20 years of legal experience, most recently 15 years at Alnylam Pharmaceuticals as SVP, Deputy General Counsel.
- At Alnylam, she advised on strategic collaborations, licensing, and capital-raising through the company's transition to commercial stage.
- PepGen CEO cites her expertise in commercial, regulatory, and policy matters as key to advancing oligonucleotide therapies.

## SEC filing metadata
- accession: 0000950170-24-004824
- form_type: 8-K
- ticker: PEPG
- cik: 0001835597
- company_name: PepGen Inc.
- filed_at: 2024-01-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835597/000095017024004824/0000950170-24-004824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835597/000095017024004824/pepg-20240117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-004824
- JSON: https://secwatch.observer/filing/0000950170-24-004824.json
- Plain text: https://secwatch.observer/filing/0000950170-24-004824.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.